Clinuvel Pharmaceuticals | CUV - Sales Revenues

Stock Price
9.47
Daily Change
-0.19 -1.97%
Monthly
-18.85%
Yearly
-20.29%
Q1 Forecast
9.72

Clinuvel Pharmaceuticals reported AUD55.92M in Sales Revenues for its fiscal semester ending in June of 2024.





Sales Change Date
Avita Medical AUD 17.61M 805K Dec/2025
Medical Developments International AUD 21.57M 12.04M Dec/2025
Mesoblast USD 51.34M 38.14M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Pacific Edge NZD 5.94M 4.95M Dec/2025
Paradigm Biopharmaceuticals AUD -8K 441.66K Jun/2025
PYC Therapeutics AUD 11.04M 2.44M Dec/2025
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025